Literature DB >> 11465479

Pituitary carcinoma: an ultrastructural study of eleven cases.

B W Scheithauer1, F Fereidooni, E Horvath, K Kovacs, P Robbins, D Tews, K Henry, P Pernicone, T A Gaffrey, F B Meyer, W F Young, R Fahlbusch, M Buchfelder, R V Lloyd.   

Abstract

Pituitary carcinomas are very rare. Defined as adenohypophysial tumors that undergo craniospinal and/or systemic metastasis, most are PRL- or ACTH-producing. Their ultrastructural features, particularly relative to benign adenomas of similar functional type, have not been sufficiently explored. Eleven cases of immunohistochemically characterized pituitary carcinoma with documented cerebrospinal and/or systemic metastases were collected from various institutions and studied by transmission electron microscopy. The tumors were surgically removed from 7 women and 4 men ranging in age between 28 and 74 years (mean, 50 years). All were endocrinologically functioning. Six tumors secreted PRL; three were ACTH-producing; one each was GH/PRL- and TSH-producing. The patients with the ACTH-producing tumors had all presented with Cushing's disease and two of them had undergone adrenalectomy (Nelson syndrome). In most cases significant cellular atypia and mitotic activity were observed. In terms of morphologic features of functional differentiation, electron microscopy revealed that in 9 cases the tumor cells maintained at least some ultrastructural markers of their basic phenotype. A unique feature in 2 ACTH carcinomas was the variable admixture of smooth endoplasmic reticulum with intermediate (cytokeratin) filaments. In 2 cases, both PRL-producing carcinomas, the cell type comprising the tumor could not be identified on an ultrastructural basis alone. Ultrastructural investigation of pituitary carcinomas confirms their endocrine nature and, in most but not all cases, reveals their functional differentiation. Despite the diagnostic utility of electron microscopy in the assessment of these rare tumors, the distinction of pituitary carcinoma from pituitary adenoma cannot be firmly made on ultrastructural grounds alone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465479     DOI: 10.1080/019131201300343865

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  15 in total

Review 1.  Clinical review: Pituitary carcinoma: difficult diagnosis and treatment.

Authors:  Anthony P Heaney
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

2.  Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.

Authors:  Carlos Kamiya-Matsuoka; David Cachia; Steven G Waguespack; Christopher H Crane; Anita Mahajan; Paul D Brown; Joo Yeon Nam; Ian E McCutcheon; Marta Penas-Prado
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

3.  Non-functioning pituitary carcinoma.

Authors:  Petra Nadja Elsässer Imboden; François-Xavier Borruat; Nicolas De Tribolet; Kathleen Meagher-Villemure; Alesia Pica; Fulgencio Gomez
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 4.  Corticotroph pituitary carcinoma: case report and literature review.

Authors:  D J Holthouse; P D Robbins; R Kahler; N Knuckey; P Pullan
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 5.  Management of aggressive pituitary adenomas and pituitary carcinomas.

Authors:  Anthony Heaney
Journal:  J Neurooncol       Date:  2014-03-02       Impact factor: 4.130

6.  Genomic instability in pituitary adenomas.

Authors:  Janusz Szymas; Karsten Schluens; Wlodzimierz Liebert; Iver Petersen
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 7.  Malignant pituitary corticotroph adenomas: report of two cases and a comprehensive review of the literature.

Authors:  Agatha A van der Klaauw; Tina Kienitz; Christian J Strasburger; Johannes W A Smit; Johannes A Romijn
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

8.  Atypical pituitary adenoma with malignant features.

Authors:  Adam N Mamelak; John D Carmichael; Patricia Park; Sergei Bannykh; Xuemo Fan; H Vivien Bonert
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

9.  A Population-Level Analysis of Pituitary Carcinoma from the National Cancer Database.

Authors:  Ryan M Carey; Edward C Kuan; Alan D Workman; Neil N Patel; Michael A Kohanski; Charles C L Tong; Jinbo Chen; James N Palmer; Nithin D Adappa; Jason A Brant
Journal:  J Neurol Surg B Skull Base       Date:  2019-03-15

10.  Metastatic pituitary carcinoma in a patient with acromegaly: a case report.

Authors:  Seamus Sreenan; Elizabeth Sengupta; William Tormey; Richard Landau
Journal:  J Med Case Rep       Date:  2012-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.